| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.24B | 1.15B | 1.10B | 1.03B | 957.04M | 1.20B |
| Gross Profit | 531.45M | 450.75M | 443.09M | 413.74M | 372.73M | 496.66M |
| EBITDA | 77.50M | 37.50M | 358.55M | -19.67M | -63.67M | 82.08M |
| Net Income | 102.62M | 42.81M | 228.96M | -44.04M | -111.83M | 46.18M |
Balance Sheet | ||||||
| Total Assets | 1.51B | 1.55B | 1.48B | 1.32B | 1.35B | 1.33B |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 1.11B | 1.20B | 769.49M | 811.06M | 980.10M |
| Total Debt | 1.75M | 2.27M | 4.32M | 6.29M | 0.00 | 0.00 |
| Total Liabilities | 309.74M | 366.19M | 337.30M | 260.45M | 243.77M | 243.75M |
| Stockholders Equity | 1.20B | 1.19B | 1.15B | 1.06B | 1.11B | 1.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -26.99M | -41.29M | -48.04M | -156.42M | 863.00K |
| Operating Cash Flow | 0.00 | -20.06M | -25.93M | -41.21M | -151.49M | 47.43M |
| Investing Cash Flow | 0.00 | -66.37M | 459.15M | 3.72M | 1.52M | -51.54M |
| Financing Cash Flow | 0.00 | -2.05M | -1.97M | -4.08M | -19.08M | 296.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥18.62B | 28.10 | ― | 0.17% | 31.39% | 13.12% | |
62 Neutral | ¥2.71B | 18.80 | ― | 0.58% | 25.37% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥51.58B | 43.46 | ― | 0.90% | 25.06% | 37.24% | |
51 Neutral | ¥2.65B | -11.01 | ― | ― | 20.46% | 37.56% | |
45 Neutral | ¥1.48B | -7.01 | ― | ― | -3.49% | -2246.63% |
SecuAvail, Inc. reported a significant financial turnaround for the six months ending September 30, 2025, with a notable increase in net sales and profitability compared to the previous year. The company’s financial results indicate a strong recovery and improved market positioning, with expectations of continued growth in the fiscal year ending March 31, 2026, as reflected in their financial forecasts.
The most recent analyst rating on (JP:3042) stock is a Hold with a Yen369.00 price target. To see the full list of analyst forecasts on SecuAvail, Inc. stock, see the JP:3042 Stock Forecast page.